STOCK TITAN

Privia Health Earns 2026 HFMA MAP Award for Revenue Cycle Excellence

(Very Positive)
Tags

Privia Health (Nasdaq: PRVA) earned the 2026 HFMA MAP Award for High Performance in Revenue Cycle, marking recognition in nine of the last ten years. The award reflects sustained excellence across MAP Keys® metrics such as net collection rate, AR performance, denial prevention, and cost to collect.

Privia’s multi-year transformation—analytics, AI automation, provider engagement, and scalable operating models—drove strong MAP benchmark results and the national award presented March 18 at the HFMA Revenue Cycle Conference.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – PRVA

-2.28%
-2.28% Session close to close

In the Mar 24 session, PRVA declined 2.28%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

ARLINGTON, Va., March 24, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced that its network of affiliated medical groups, collectively Privia Medical Group, has been named a recipient of the 2026 MAP (Measure, Apply, Perform) Award for High Performance in Revenue Cycle, sponsored by the Healthcare Financial Management Association (HFMA).

Privia Health has been recognized by HFMA for its revenue cycle capabilities and performance in nine of the last ten years.

The MAP Award is one of the healthcare industry’s most respected distinctions, highlighting organizations that demonstrate sustained excellence across key revenue cycle metrics, including net collection rate, accounts receivable performance, denial prevention, and cost to collect. As a national award winner, Privia Health met or exceeded industry-standard revenue cycle benchmarks (MAP Keys®) while advancing patient-centered best practices aligned with HFMA’s Healthcare Dollars & Sense® initiative.

“Consistent recognition from HFMA reflects the strength of our revenue cycle operations and the collaboration across our teams to deliver a seamless, patient-centered financial experience,” said Melanie Suranto, Senior Vice President, Revenue Cycle Management and Credentialing at Privia Health. “This achievement is a testament to the discipline, innovation, and commitment of our teams nationwide to deliver value for both clinicians and patients.”

The award was presented on March 18 at the HFMA Revenue Cycle Conference in Arlington, Texas.

Privia Health’s performance was driven by a multi-year transformation strategy focused on:

  • Advanced analytics and KPI discipline to drive accountability and transparency
  • AI-enabled automation and workflow optimization to improve efficiency and accuracy
  • Enhanced provider engagement and education to strengthen front-end performance
  • Scalable operating models to support growth across diverse markets

These efforts resulted in strong performance across HFMA’s MAP benchmarks, reinforcing Privia Health’s position as a leader in revenue cycle innovation and execution.

About Privia Health
Privia Health™ is one of the largest physician enablement companies in the United States with a presence in 24 states and the District of Columbia. Privia builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. Privia collaborates with medical groups, health plans and health systems to optimize 1,300+ physician practices, improve the patient experience for 5.8+ million patients, and reward 5,300+ physicians and advanced practitioners for delivering high-value care.

Privia’s mission is to transform healthcare delivery to achieve better outcomes, lower costs, and improve the health of communities and the well-being of providers. For more information, visit priviahealth.com.

Contact
Robert Borchert
SVP, Investor & Corporate Communications
IR@priviahealth.com
817.783.4841


FAQ

What did Privia Health announce about the 2026 HFMA MAP Award (PRVA)?

Privia Health announced it received the 2026 HFMA MAP Award for Revenue Cycle Excellence, a national recognition. According to the company, this marks MAP recognition in nine of the last ten years and reflects strong performance across HFMA MAP Keys® metrics.

Which revenue cycle metrics led to Privia Health winning the 2026 MAP Award (PRVA)?

The award highlighted performance in net collection rate, accounts receivable, denial prevention, and cost to collect. According to the company, meeting or exceeding HFMA MAP Keys® benchmarks across these metrics drove the recognition.

When and where was Privia Health presented the 2026 HFMA MAP Award (PRVA)?

The award was presented on March 18, 2026, at the HFMA Revenue Cycle Conference. According to the company, the presentation took place during the conference in Arlington, Texas, recognizing national high performance.

What operational changes did Privia Health cite as driving MAP Award success (PRVA)?

Privia Health cited advanced analytics, AI-enabled automation, enhanced provider engagement, and scalable operating models as drivers of success. According to the company, these multi-year initiatives improved efficiency, accuracy, and front-end performance.

How often has Privia Health been recognized by HFMA with MAP Awards (PRVA)?

Privia Health has been recognized by HFMA in nine of the last ten years for revenue cycle performance. According to the company, this reflects sustained, repeat recognition across a multi-year period.

What does the 2026 MAP Award mean for Privia Health patients and clinicians (PRVA)?

The award signals Privia Health’s emphasis on a seamless, patient-centered financial experience and clinician value. According to the company, disciplined revenue cycle practices aim to improve transparency, reduce denials, and support clinicians nationwide.